Clinical and pharmacological group: & nbsp

Antiseptics and disinfectants

Local Anesthetics

Included in the formulation
  • Instillagel®
    gel locally 
    Farco-Pharma GmbH     Germany
  • Lidocaine cage
    gel locally 
  • Lidocaine Asept
    spray locally 
    BIOGEN NPC, OAO     Russia
  • АТХ:

    N.01.B.B.52   Lidocaine in combination with other drugs

    Pharmacodynamics:

    Combined drug, which has antiseptic and local anesthetic effect. Chlorhexidine - antimicrobial drug, acting on gram-positive and gram-negative microorganisms, yeast, dermatophytes. Effective against gram-positive and gram-negative bacteria - Treponema spp., Neisseria gonorrhoeae, Trichomonas spp., Chlamydia spp., Ureaplasma spp. Keeps activity (although somewhat reduced) in the presence of blood, pus, various secrets and organic substances. Lidocaine - local anesthetic. Antimicrobial action and adequate anesthesia develop 5-10 minutes after application of the drug. Water-soluble clear gel provides a clear optical view, has a lubricating effect for various endoscopic procedures.

    Pharmacokinetics:

    Not studied.

    Indications:

    Prevention of infection; anesthesia in operative and diagnostic endoscopic interventions in children and adults in urology, gynecology, proctology (all forms of endoscopy, replacement of fistula catheters), intubation.

    Kupirovanie symptoms of inflammation accompanied by pain syndrome, the mucous membrane of the urethra, vagina, cervical canal and rectum (in complex therapy).

    XXI.Z40-Z54.Z51.4   Preparatory procedures for subsequent treatment, not elsewhere classified

    Contraindications:

    Hypersensitivity.

    Carefully:No data.
    Pregnancy and lactation:

    With caution in I trimester of pregnancy. In the case of lactation, refrain from breastfeeding for 12 hours after use.

    FDA recommendations are not defined.

    Dosing and Administration:

    Locally.

    Side effects:

    With increased sensitivity, allergic reactions are possible (allergic dermatitis, skin rash, angioedema), burning at the place of application.

    Overdose:

    Symptoms (with systemic action of lidocaine in cases of severe damage to the urethra): bradycardia, convulsions, collapse.

    Treatment: with bradycardia - beta-adrenostimulators, with convulsions - barbiturates or short-acting muscle relaxants, in case of collapse - epinephrine or dopamine is administered intravenously.

    Interaction:

    Avoid joint use with iodine preparations.

    MAO inhibitors enhance the local anesthetic effect of lidocaine. Incompatible with soaps, as well as detergents containing an anionic group, saponins, sodium lauryl sulfate, sodium carboxymethylcellulose. Compatible with drugs containing a cationic group (benzalkonium chloride).

    Special instructions:

    The drug is sterile and is intended for single administration.

    In the case of lactation, refrain from breastfeeding for 12 hours after use.

    Instructions
    Up